Robotic Surgery Systems Revenue Growth measures the year-over-year change in Intuitive's systems revenue.
Systems revenue increased 26% in 2025, to $2.474 billion from $1.966 billion.
Revenue growth is not placement growth
Intuitive's systems revenue grew 26% while da Vinci placements grew 13% in 2025. The difference illustrates why unit growth alone does not explain system revenue. Da Vinci 5 mix, trade-ins, lease buyouts, average selling prices, and the timing of operating lease revenue all affect the revenue line.
Investor caution
A higher systems-revenue growth rate does not by itself imply higher unit pricing or better economics. Financing mix and product transition can materially change the timing and composition of recognized revenue.
Source:
Part of the Robotic Surgery Platform Economics
See It in Company Research
These companies are examples of how the concept is reported or discussed in public filings. Definitions can differ by issuer; these links open company research rather than a normalized metric comparison.
- ISRGOpen operating-model research →17 of 17 reviewed concepts in Robotic Surgery Platform EconomicsPlacements, financing mix, and system revenue timing6 of 6 bridge concepts supportedContinue through this bridge:da Vinci Placement Growthda Vinci System PlacementsOperating Lease Placement MixOperating Lease RevenueSystems Revenue
Continue Research
Continue from the concept into the Grizzly Bulls research surface that best matches the next question. These links are research continuations, not recommendations or required steps.
Compare medical device stocks
Continue into stock comparison for installed-base growth, procedure utilization, recurring revenue, and system-financing economics.
Explore more topics in the Financial Research Encyclopedia.